Agonists and Antagonists
- Forskolin [orb154708]
[66575-29-9]
410.5012
C22H34O7
O1[C@](C([H])=C([H])[H])(C([H])([H])[H])C([H])([H])C([C@]2([C@@]1(C([H])([H])[H])[C@]([H])([C@]([H])([C@@]1([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])C([H])([H])[C@@]([H])([C@@]12C([H])([H])[H])O[H])O[H])OC(C([H])([H])[H])=O)O[H])=O
10 mM * 1 mL in DMSO, 1 g - Cinacalcet (AMG-073) HCl [orb154689]
[364782-34-3]
393.8729
C22H23CLF3N
Cl[H].FC(C1=C([H])C([H])=C([H])C(=C1[H])C([H])([H])C([H])([H])C([H])([H])N([H])[C@]([H])(C([H])([H])[H])C1=C([H])C([H])=C([H])C2=C([H])C([H])=C([H])C([H])=C12)(F)F
10 mM * 1 mL in DMSO, 100 mg, 250 mg, 1 g - lurasidone [orb154672]
[367514-87-2]
492.682
C28H36N4O2S
C1CC[C@H]([C@@H](C1)CN2CCN(CC2)C3=NSC4=CC=CC=C43)CN5C(=O)[C@H]6[C@@H]7CC[C@@H](C7)[C@H]6C5=O
100 mg, 250 mg, 1 g - Pramipexole dihydrochloride [orb154668]
[104632-25-9]
284.25
C10H17N3S.2(HCl)
NC(S1)=NC2=C1C[C@@H](NCCC)CC2.[H]Cl.[H]Cl
100 mg, 250 mg, 1 g - Tiotropium Bromide hydrate (BA679BR) [orb154653]
[139404-48-1]
490.43
C19H22NO4S2.Br.xH2O
OC(C1=CC=CS1)(C(O[C@H]2C[C@@]([N+]3(C)C)([H])[C@@H]4O[C@@H]4[C@@]3([H])C2)=O)C5=CC=CS5.[Br-].O
100 mg, 250 mg, 1 g - Escitalopram oxalate [orb154634]
[219861-08-2]
414.43
C20H21FN2O.C2H2O4
FC1=CC=C([C@@]2(CCCN(C)C)C(C=CC(C#N)=C3)=C3CO2)C=C1.O=C(O)C(O)=O
100 mg, 250 mg, 1 g - Fingolimod HCl (FTY-720) [orb154632]
[162359-56-0]
343.94
C19H34ClNO2
NC(CO)(CO)CCC1=CC=C(CCCCCCCC)C=C1.Cl
10 mM * 1 mL in DMSO, 100 mg, 250 mg, 1 g - CP-945598 [orb154630]
[686347-12-6]
546.881
C25H26Cl3N7O
[H]Cl.ClC1=CC=CC=C1C2=NC3=C(N4CCC(NCC)(C(N)=O)CC4)N=CN=C3N2C5=CC=C(Cl)C=C5
100 mg, 250 mg, 1 g - Cisapride [orb146300]
[81098-60-4]
465.9455
C23H29CLFN3O4
ClC1=C(C([H])=C(C(=C1[H])C(N([H])C1([H])C([H])([H])C([H])([H])N(C([H])([H])C([H])([H])C([H])([H])OC2C([H])=C([H])C(=C([H])C=2[H])F)C([H])([H])C1([H])OC([H])([H])[H])=O)OC([H])([H])[H])N([H])[H]
1 g - Metroprolol succinate [orb146298]
[98418-47-4]
385.45194
C19H31NO7
OC(CNC(C)C)COC1=CC=C(CCOC)C=C1.OC(CNC(C)C)COC2=CC=C(CCOC)C=C2.OC(CCC(O)=O)=O
100 mg, 250 mg, 1 g